Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice
Author(s) -
Cristina CasanovaMartínez,
Elena Yaiza RomeroVentosa,
Sonia GonzálezCostas,
Cecilia Arroyo-Conde,
Guadalupe PiñeiroCorrales
Publication year - 2018
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.188292
Subject(s) - gemcitabine , medicine , regimen , neutropenia , nausea , oncology , pancreatic cancer , nab paclitaxel , adverse effect , vomiting , paclitaxel , observational study , retrospective cohort study , toxicity , surgery , cancer
Pancreatic cancer in a common tumor in our country for which there are various treatment alternatives.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom